HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

被引：0
|
作者：
J. R. Ribeiro
C. Schorl
N. Yano
N. Romano
K. K. Kim
R. K. Singh
R. G. Moore
机构：
[1] Women and Infants Hospital,Center for Genomics and Proteomics, Genomics Core Facility
[2] Department of Obstetrics and Gynecology,Wilmot Cancer Institute, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
[3] Program in Women’s Oncology,undefined
[4] Molecular Therapeutics Laboratory,undefined
[5] Brown University,undefined
[6] University of Rochester Medical Center,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
HE4; Epithelial ovarian cancer; Chemoresistance; Paclitaxel resistance; Platinum resistance; MAPK signaling; Tubulin; EGR1; SKOV3 cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Detection of urinary HE4 as a biomarker for epithelial ovarian cancer
    Li, Zhong-Qian
    Radwan, Rachel
    Polkowski, Julie
    Raju, Savitha
    Falcone, Katherine
    Simamora, Rebecca
    Kettlety, Timothy
    Moore, Richard G.
    Barnes, Grady
    CANCER RESEARCH, 2011, 71
  • [22] Validation of urinary HE4 as a biomarker for ovarian cancer.
    Li, Zhong-Qian
    Fermer, Christian
    Radwan, Rachel R.
    Hellman, Maria
    He, Kuanglin
    Falcone, Katherine L.
    Raju, Savitha S.
    Fegely, Maryellen
    Vucetic, Zivjena
    Dickson, Diana L.
    Kettlety, Timothy R.
    Moore, Richard G.
    Barnes, Grady
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Does HE4 have a role in the recurrence of ovarian cancer?
    Montera, Roberto
    Plotti, Francesco
    Muzii, Ludovico
    Terranova, Corrado
    Angelucci, Michela
    Oronzi, Irma
    Damiani, Patrizio
    Dugo, Nella
    Guzzo, Federica
    De Oronzo, Maria Antonietta
    Ricciardi, Roberto
    Aloisi, Alessia
    Luvero, Daniela
    Portuesi, Rosa Alba Valentina
    Scaletta, Giuseppe
    Capriglione, Stella
    Linciano, Francesca
    Gennari, Paolo
    Panici, Pierluigi Benedetti
    Angioli, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Place of HE4 and ROMA score in the diagnosis of ovarian cancer
    Laiche, Naima
    Jayi, Sofia
    Belhaj, Yassine
    Alaoui, Fatima Zohra Fdili
    Chaara, Hekmat
    Melhouf, Moulay Abdelilah
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A404 - A404
  • [25] HE4 IN OVARIAN CANCER: FROM DISCOVERY TO CLINICAL APPLICATION
    Montagnana, M.
    Danese, E.
    Giudici, S.
    Franchi, M.
    Guidi, G. C.
    Plebani, M.
    Lippi, G.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 55, 2011, 55 : 1 - 20
  • [26] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [27] HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells
    James, N. E.
    Cantillo, E.
    Oliver, M. T.
    Rowswell-Turner, R. B.
    Ribeiro, J. R.
    Kim, K. -K.
    Chichester, C. O.
    DiSilvestro, P. A.
    Moore, R. G.
    Singh, R. K.
    Yano, N.
    Zhao, T. C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 193 (03): : 327 - 340
  • [28] Transcriptome Remodeling in Gradual Development of Inverse Resistance between Paclitaxel and Cisplatin in Ovarian Cancer Cells
    Szenajch, Jolanta
    Szabelska-Beresewicz, Alicja
    Swiercz, Aleksandra
    Zyprych-Walczak, Joanna
    Siatkowski, Idzi
    Goralski, Michal
    Synowiec, Agnieszka
    Handschuh, Luiza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 30
  • [29] Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
    Wang, Yue
    Qu, Ye
    Niu, Xiu Long
    Sun, Wei Jia
    Zhang, Xiao Lei
    Li, Ling Zhi
    CYTOKINE, 2011, 56 (02) : 365 - 375
  • [30] Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
    Wang, Yue
    Niu, Xiu Long
    Qu, Ye
    Wu, Jian
    Zhu, Ya Qin
    Sun, Wei Jia
    Li, Ling Zhi
    CANCER LETTERS, 2010, 295 (01) : 110 - 123
12345